← Back to patent-cliff list
CAS 1186400-77-0
benzyl 7-methoxy-2,3-dihydrobenzo[f][1,4]thiazepine-4(5H)-carboxylate
Codes: ARM-210-005
Application context (from source-drug indications)
常染色体显性遗传性RYR1相关肌病SurlorianVentricular tachycardiaSurlorian
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Surlorian | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
ARM-210→4-methoxybenzenethiol→2-chloroethan-1-amine hydrochloride→2-((4-methoxyphenyl)thio)ethan-1-amine→benzyl (2-((4-methoxyphenyl)thio)ethyl)carbamate→benzyl 7-methoxy-2,3-dihydrobenzo[f][1,4]thiazepine-4(5H)-carboxylate→7-methoxy-2,3,4,5-tetrahydrobenzo[f][1,4]thiazepine hydrobromide→methyl 4-(((methylsulfonyl)oxy)methyl)benzoate→methyl 4-((7-methoxy-2,3-dihydrobenzo[f][1,4]thiazepin-4(5H)-yl)methyl)benzoate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.